Forte Biosciences (FBRX) Short Interest Ratio & Short Volume $12.54 -0.06 (-0.48%) As of 06/12/2025 02:08 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Forte Biosciences Short Interest DataForte Biosciences (FBRX) has a short interest of 173,300 shares, representing 3.25% of the float (the number of shares available for trading by the public). This marks a 33.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 158,034 shares to cover all short positions.Current Short Interest173,300 sharesPrevious Short Interest129,800 sharesChange Vs. Previous Month+33.51%Dollar Volume Sold Short$1.46 millionShort Interest Ratio3.6 Days to CoverLast Record DateMay 31, 2025Outstanding Shares6,583,000 sharesFloat Size5,330,000 sharesShort Percent of Float3.25%Today's Trading Volume4,848 sharesAverage Trading Volume158,034 sharesToday's Volume Vs. Average3% Short Selling Forte Biosciences? Sign up to receive the latest short interest report for Forte Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFBRX Short Interest Over TimeFBRX Days to Cover Over TimeFBRX Percentage of Float Shorted Over Time Forte Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2025173,300 shares $1.46 million +33.5%3.3%3.6 $8.40 5/15/2025129,800 shares $1.02 million +18.5%2.4%2.9 $7.83 4/30/2025109,500 shares $799.35 thousand +4.5%2.1%3.2 $7.30 4/15/2025104,800 shares $612.03 thousand -11.2%2.0%3 $5.84 3/31/2025118,000 shares $915.68 thousand +761.3%2.2%3 $7.76 3/15/202513,700 shares $79.46 thousand +9.6%0.3%0.3 $5.80 2/28/202512,500 shares $113.75 thousand -55.8%0.2%0.2 $9.10 2/15/202528,300 shares $339.60 thousand -79.0%0.6%0.1 $12.00 1/31/2025134,600 shares $2.14 million -44.2%2.3%0.2 $15.89 1/15/2025241,300 shares $3.98 million -29.6%4.2%0.4 $16.50 Get the Latest News and Ratings for FBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024342,900 shares $7.79 million +19.9%5.6%0.6 $22.71 12/15/2024286,000 shares $6.62 million +35.4%20.3%0.5 $23.15 11/30/2024211,200 shares $4.59 million +6,111.8%16.5%0.4 $21.71 11/15/20243,400 shares $18.94 thousand +240.0%0.3%0 $5.57 10/31/20241,000 shares $4.45 thousand -75.6%0.1%0.1 $4.45 10/15/20244,100 shares $18.94 thousand +24.2%0.3%0.4 $4.62 9/30/20243,300 shares $18.45 thousand -2.9%0.3%0.4 $5.59 9/15/20243,400 shares $24.75 thousand -40.4%0.3%0.6 $7.28 8/31/20245,700 shares $45.03 thousand -75.6%0.4%1.2 $7.90 8/15/202423,400 shares $7.18 thousand +157.1%N/A0.3 $0.31 7/31/20249,100 shares $5.01 thousand -22.9%N/A0.5 $0.55 7/15/202411,800 shares $6.60 thousand -41.9%N/A0.6 $0.56 6/30/202420,300 shares $10.90 thousand +18.7%N/A1 $0.54 6/15/202417,100 shares $9.56 thousand +0.6%N/A0.7 $0.56 5/31/202417,000 shares $10.09 thousand -32.3%N/A0.7 $0.59 5/15/202425,100 shares $16.06 thousand -12.9%N/A1 $0.64 4/30/202428,800 shares $21.05 thousand -12.7%N/A1 $0.73 4/15/202433,000 shares $23.43 thousand -3.2%N/A1 $0.71 3/31/202434,100 shares $23.74 thousand -19.2%N/A1 $0.70 3/15/202442,200 shares $26.16 thousand -36.6%N/A1.2 $0.62 2/29/202466,600 shares $45.47 thousand -17.2%N/A1.6 $0.68 2/15/202480,400 shares $55.91 thousand +62.4%N/A2.1 $0.70 1/31/202449,500 shares $30.20 thousand -28.7%N/A1.1 $0.61 1/15/202469,400 shares $51.36 thousand -55.4%N/A1.8 $0.74 12/31/2023155,500 shares $127.77 thousand +57.1%N/A3.9 $0.82 12/15/202399,000 shares $74.25 thousand +40.4%N/A2.5 $0.75 11/30/202370,500 shares $33.42 thousand +21.6%N/A1.7 $0.47 11/15/202358,000 shares $22.05 thousand +3.2%N/A1.5 $0.38 10/31/202356,200 shares $27.59 thousand -2.9%N/A1.8 $0.49 10/15/202357,900 shares $33.02 thousand -10.9%N/A0.7 $0.57The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 9/30/202365,000 shares $43.03 thousand -0.8%N/A0.8 $0.66 9/15/202365,500 shares $53.68 thousand -1.8%N/A0.8 $0.82 8/31/202366,700 shares $55.37 thousand -7.6%N/A0.8 $0.83 8/15/202372,200 shares $59.20 thousand +38.3%N/A0.9 $0.82 7/31/202352,200 shares $52.72 thousand -7.6%N/A0.7 $1.01 7/15/202356,500 shares $56.50 thousand -0.9%N/A1.8 $1.00 6/30/202357,000 shares $59.28 thousand +4.8%N/A0.9 $1.04 6/15/202354,400 shares $56.03 thousand +0.4%N/A0.9 $1.03 5/31/202354,200 shares $55.28 thousand -4.1%N/A0.8 $1.02 5/15/202356,500 shares $61.08 thousand -15.7%N/A0.8 $1.08 4/30/202367,000 shares $71.69 thousand -42.4%N/A1 $1.07 4/15/2023116,400 shares $125.71 thousand +203.9%N/A1.7 $1.08 3/31/202338,300 shares $38.68 thousand -27.3%N/A0.6 $1.01 3/15/202352,700 shares $52.00 thousand -23.0%N/A1.3 $0.99 2/28/202368,400 shares $69.77 thousand +0.4%N/A1.7 $1.02 2/15/202368,100 shares $68.10 thousand -2.4%N/A1.7 $1.00 1/31/202369,800 shares $69.80 thousand +0.7%N/A1.7 $1.00 1/15/202369,300 shares $70.69 thousand -39.5%N/A1.7 $1.02 12/30/2022114,500 shares $114.50 thousand +36.8%N/A2.8 $1.00 12/15/202283,700 shares $85.37 thousand -16.3%N/A2.1 $1.02 11/30/2022100,000 shares $99.48 thousand -19.4%N/A1.9 $0.99 11/15/2022124,100 shares $124.10 thousand +17.1%N/A1.9 $1.00 10/31/2022106,000 shares $114.48 thousand +1.7%N/A1.2 $1.08 10/15/2022104,200 shares $107.33 thousand -10.8%N/A0.7 $1.03 9/30/2022116,800 shares $124.98 thousand +8.4%N/A0.6 $1.07 9/15/2022107,800 shares $137.98 thousand -2.3%N/A0.4 $1.28 8/31/2022110,300 shares $143.39 thousand -30.6%N/A0.4 $1.30 8/15/2022159,000 shares $206.70 thousand -3.0%N/A0.6 $1.30 7/31/2022163,900 shares $203.24 thousand +7.2%1.4%0.6 $1.24 7/15/2022152,900 shares $194.18 thousand -29.2%1.2%0.6 $1.27 6/30/2022215,900 shares $280.67 thousand -62.1%1.7%1.1 $1.30 6/15/2022569,500 shares $694.79 thousand +1.9%4.5%3 $1.22 5/31/2022559,000 shares $737.88 thousand +14.1%4.5%3.5 $1.32 5/15/2022490,100 shares $578.32 thousand -7.3%4.0%3 $1.18 4/30/2022528,800 shares $608.12 thousand +18.5%4.3%3.4 $1.15 4/15/2022446,100 shares $633.46 thousand +9.7%3.6%2.7 $1.42 3/31/2022406,800 shares $593.93 thousand +14.2%3.3%2.2 $1.46 3/15/2022356,100 shares $498.54 thousand -5.1%2.9%1.6 $1.40 2/28/2022375,300 shares $472.88 thousand +0.8%3.0%1.2 $1.26 2/15/2022372,500 shares $540.13 thousand -61.5%3.0%1.1 $1.45 1/31/2022968,000 shares $1.64 million +8.5%7.8%2.5 $1.69 1/15/2022892,500 shares $1.54 million -1.2%7.2%1.8 $1.72 12/31/2021903,300 shares $1.93 million +107.0%7.3%1.6 $2.14 12/15/2021436,400 shares $881.53 thousand -30.5%3.5%0.6 $2.02 11/30/2021627,800 shares $1.67 million -12.7%5.1%0.5 $2.66 11/15/2021719,200 shares $2.39 million -35.8%5.9%0.3 $3.33 10/29/20211,120,000 shares $3.04 million -6.7%9.6%0.5 $2.71 10/15/20211,200,000 shares $3.34 million -17.8%10.2%0.5 $2.78 9/30/20211,460,000 shares $4.32 million -46.7%12.5%0.7 $2.96 9/15/20212,740,000 shares $9.56 million +67.1%23.4%1.4 $3.49The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 8/31/20211,640,000 shares $48.25 million -4.7%16.1%1.1 $29.42 8/13/20211,720,000 shares $43.60 million +1.8%16.9%7.6 $25.35 7/30/20211,690,000 shares $50.63 million +20.7%17.3%8.4 $29.96 7/15/20211,400,000 shares $43.13 million +10.2%14.3%7.6 $30.81 6/30/20211,270,000 shares $42.70 million +38.5%13.0%7.3 $33.62 6/15/2021916,800 shares $36.52 million +2.5%9.4%4.9 $39.83 5/28/2021894,100 shares $31.78 million -12.3%9.1%4.2 $35.54 5/14/20211,020,000 shares $32.13 million -1.0%10.4%4.6 $31.50 4/30/20211,030,000 shares $37.85 million +32.1%10.5%4.7 $36.75 4/15/2021779,800 shares $28.37 million +27.9%52.3%3.8 $36.38 3/31/2021609,600 shares $19.62 million -6.1%41.2%3.1 $32.18 3/15/2021648,900 shares $19.20 million +109.5%43.8%4.9 $29.59 2/26/2021309,800 shares $8.72 million -13.0%20.9%3.5 $28.16 2/12/2021355,900 shares $12.65 million +0.7%24.1%4.7 $35.53 1/29/2021353,300 shares $12.18 million +4.0%23.7%5.4 $34.47 1/15/2021339,700 shares $12.89 million No Change22.8%4.9 $37.95 FBRX Short Interest - Frequently Asked Questions What is Forte Biosciences' current short interest? Short interest is the volume of Forte Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 173,300 shares of FBRX short. 3.25% of Forte Biosciences' shares are currently sold short. Learn More on Forte Biosciences' current short interest. What is a good short interest ratio for Forte Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FBRX shares currently have a short interest ratio of 4.0. Learn More on Forte Biosciences's short interest ratio. What is a good short interest percentage for Forte Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.25% of Forte Biosciences' floating shares are currently sold short. Is Forte Biosciences' short interest increasing or decreasing? Forte Biosciences saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 173,300 shares, an increase of 33.5% from the previous total of 129,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Forte Biosciences' float size? Forte Biosciences currently has issued a total of 6,583,000 shares. Some of Forte Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Forte Biosciences currently has a public float of 5,330,000 shares. How does Forte Biosciences' short interest compare to its competitors? 3.25% of Forte Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Forte Biosciences: Allogene Therapeutics, Inc. (15.48%), Monte Rosa Therapeutics, Inc. (17.57%), Entrada Therapeutics, Inc. (4.91%), Gossamer Bio, Inc. (5.15%), Olema Pharmaceuticals, Inc. (13.64%), Canopy Growth Co. (9.91%), Candel Therapeutics, Inc. (16.16%), Tonix Pharmaceuticals Holding Corp. (14.48%), ProKidney Corp. (18.12%), Annexon, Inc. (10.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Forte Biosciences stock? Short selling FBRX is an investing strategy that aims to generate trading profit from Forte Biosciences as its price is falling. FBRX shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Forte Biosciences? A short squeeze for Forte Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FBRX, which in turn drives the price of the stock up even further. How often is Forte Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBRX, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Allogene Therapeutics Short Squeeze Monte Rosa Therapeutics Short Squeeze Entrada Therapeutics Short Squeeze Gossamer Bio Short Squeeze Olema Pharmaceuticals Short Squeeze Canopy Growth Short Squeeze Candel Therapeutics Short Squeeze Tonix Pharmaceuticals Short Squeeze ProKidney Short Squeeze Annexon Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FBRX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.